How companies are moving beyond assistive tools to deploying agentic systems, and marking a fundamental shift in how they ...
The first and only approved achondroplasia therapy to provide continuous systemic exposure to CNP over the weekly dosing intervalCommercial availability expected during early part of Q2 2026Rare Pedia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results